Yimei Zhang

ORCID: 0000-0003-3125-8584
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nanoplatforms for cancer theranostics
  • Photodynamic Therapy Research Studies
  • Advanced biosensing and bioanalysis techniques
  • Boron Compounds in Chemistry
  • Nanocluster Synthesis and Applications
  • Nanoparticle-Based Drug Delivery
  • Advanced Breast Cancer Therapies

Chongqing University of Arts and Sciences
2022-2023

Chongqing University
2022-2023

Palbociclib is the world's first CDK4/6 kinase inhibitor to be marketed. However, it not effective in treatment of triple negative breast cancer (TNBC) due loss retinoblastoma protein expression. Thus, combinatorial chemotherapy indispensable for TNBC treatment. Herein, a carrier-free nanomedicine self-assembled from palbociclib dimers and Ce6 enhanced combined chemo-photodynamic therapy reported. The dimeric prodrug (Palb-TK-Palb) was synthesized by conjugating two molecules connecting...

10.1039/d2ra05932k article EN cc-by-nc RSC Advances 2023-01-01

Photodynamic therapy (PDT) is an effective noninvasive therapeutic strategy that has been widely used for anti-tumor by the generation of excessive highly cytotoxic ROS. However, poor water solubility photosensitizer, reactive oxygen species (ROS) depleting high concentrations glutathione (GSH) in tumor microenvironment and activation DNA repair pathways to combat oxidative damage, will significantly limit effect PDT. Herein, we developed a photosensitizer prodrug (CSP) conjugating...

10.3390/molecules28196972 article EN cc-by Molecules 2023-10-07

Mitochondrial dysfunction is a feature of cancer cells and targeting mitochondria has emerged as promising anticancer therapy.

10.1039/d2nj01157c article EN New Journal of Chemistry 2022-01-01
Coming Soon ...